seattle genetics | Seagen - Dedicated to revolutionizing cancer care

Keyword	CPC	PCC	Volume	Score	Length of keyword
seattle genetics	0.33	0.4	7736	41	16
seattle	1.56	0.3	8097	16	7
genetics	0.43	0.2	9723	72	8

Keyword	CPC	PCC	Volume	Score
seattle genetics	0.42	0.1	1275	96
seattle genetics stock	0.74	0.9	6483	2
seattle genetics careers	0.86	0.6	8196	52
seattle genetics seagen	1.06	1	1735	1
seattle genetics stock news	1.73	1	501	60
seattle genetics pfizer	0.32	0.8	6277	98
seattle genetics stock price	0.29	1	2631	73
seattle genetics news	0.8	0.3	173	38
seattle genetics bothell wa	1.78	0.6	567	92
seattle genetics cafepharma	1.66	0.3	8691	45
seattle genetics merger	0.36	0.3	3603	68
seattle genetics website	0.13	0.7	6432	66
seattle genetics inc	1.39	0.7	4337	68
seattle children's genetics	0.71	0.8	4318	15
seattle children's hospital genetics clinic	0.12	0.1	4456	92
biochemical genetics seattle children's	1.7	0.4	9131	26
jason howard seattle genetics linkedin	0.28	0.3	1433	57

Search Results related to seattle genetics on Search Engine

Seagen - Dedicated to revolutionizing cancer care
seagen.com

https://www.seagen.com/

WebAs a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering safe and effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumors and blood-related ...

DA: 74 PA: 82 MOZ Rank: 80

Seagen - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Seagen

WebSeagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody -based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle ), is the industry leader in antibody-drug conjugates or …

DA: 78 PA: 86 MOZ Rank: 32

Pfizer will acquire Seattle-area biotech giant Seagen for ... - GeekWire
geekwire.com

https://www.geekwire.com/2023/pfizer-will-acquire-seattle-area-biotech-giant-seagen-for-43-billion/

WebMar 13, 2023 · Seagen was previously known as Seattle Genetics when it launched back in 1998. It went public in 2001, pricing its IPO at $7 per share. The new deal values the company at approximately $229 per...

DA: 36 PA: 16 MOZ Rank: 45

Science and Research – Seagen
seagen.com

https://www.seagen.com/science

WebSeagen is an industry leader in innovative, targeted drug delivery. ADC technology harnesses the power of potent payloads and the specificity of antibodies to selectively deliver small molecule drugs to tumors. Our proprietary ADC technologies are designed to target cancer cells with greater precision, reducing side effects.

DA: 22 PA: 62 MOZ Rank: 90

Our History – Seagen
seagen.com

https://www.seagen.com/who-we-are/history

WebSeattle Genetics, Inc. changes its name to Seagen Inc. to reflect the transformation of the company from its Seattle roots into a global operation. 2021 TIVDAK® (tisotumab vedotin-tftv) receives accelerated approval in the U.S. – our fourth approved medicine.

DA: 52 PA: 20 MOZ Rank: 98

Pfizer buys Bothell-based Seagen for $43B | The Seattle Times
seattletimes.com

https://www.seattletimes.com/business/pfizer-will-spend-43-billion-to-acquire-seagen/

WebMar 13, 2023 · Pfizer is spending about $43 billion to acquire Seagen, the Bothell-based biotech giant formerly known as Seattle Genetics. Pfizer plans to let the cancer treatment developer “continue...

DA: 28 PA: 7 MOZ Rank: 50

Seattle Genetics, Inc. Announces Corporate Name Change to …
businesswire.com

https://www.businesswire.com/news/home/20201008005358/en/Seattle-Genetics-Inc.-Announces-Corporate-Name-Change-to-Seagen-Inc.

WebOct 8, 2020 · BOTHELL, Wash.-- ( BUSINESS WIRE )--Seagen Inc. is the new corporate name for Seattle Genetics, Inc. (Nasdaq:SGEN), a global biotechnology company dedicated to developing innovative cancer...

DA: 59 PA: 65 MOZ Rank: 38

Seattle Genetics gets $1 billion investment from Merck in cancer …
seattletimes.com

https://www.seattletimes.com/business/seattle-genetics-gets-1-billion-investment-from-merck-in-cancer-deal-potentially-worth-billions-more/

WebSep 14, 2020 · Seattle Genetics shares jumped $21.82, or 14.6%, to close Monday at $171.79. The companies will develop an experimental medicine, ladiratuzumab vedotin or LV, that has shown signs of early...

DA: 41 PA: 87 MOZ Rank: 50

Seattle Genetics takes a new identity | The Seattle Times
seattletimes.com

https://www.seattletimes.com/business/technology/seattle-genetics-takes-a-new-identity/

WebOct 8, 2020 · Technology. Seattle Genetics takes a new identity. Oct. 8, 2020 at 3:12 pm Updated Oct. 8, 2020 at 5:27 pm. By. Seattle Times business staff. After more than two decades that saw it become...

DA: 20 PA: 48 MOZ Rank: 45

Seattle Genetics wins another speedy approval as FDA clears …
biopharmadive.com

https://www.biopharmadive.com/news/seattle-genetics-fda-approval-breast-cancer-tucatinib/576311/

WebApr 17, 2020 · The Food and Drug Administration on Friday approved Seattle Genetics’ drug Tukysa as a treatment for patients whose advanced breast cancer expresses the HER2 protein and has spread to other areas of the body, including the brain.

DA: 65 PA: 66 MOZ Rank: 29